Literature DB >> 28885721

Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.

Devendra H Dusane1, Douglas Kyrouac1, Iris Petersen1, Luke Bushrow1, Jason H Calhoun2, Jeffrey F Granger2, Laura S Phieffer2, Paul Stoodley1,2,3.   

Abstract

Staphylococcus aureus is often found in orthopaedic infections and may be protected from commonly prescribed antibiotics by forming biofilms or growing intracellularly within osteoblasts. To investigate the effect of non-antibiotic compounds in conjunction with antibiotics to clear intracellular and biofilm forming S. aureus causing osteomyelitis. SAOS-2 osteoblast-like cell lines were infected with S. aureus BB1279. Antibiotics (vancomycin, VAN; and dicloxacillin, DICLOX), bacterial efflux pump inhibitors (piperine, PIP; carbonyl cyanide m-chlorophenyl hydrazone, CCCP), and bone morphogenetic protein (BMP-2) were evaluated individually and in combination to kill intracellular bacteria. We present direct evidence that after gentamicin killed extracellular planktonic bacteria and antibiotics had been stopped, seeding from the infected osteoblasts grew as biofilms. VAN was ineffective in treating the intracellular bacteria even at 10× MIC; however in presence of PIP or CCCP the intracellular S. aureus was significantly reduced. Bacterial efflux pump inhibitors (PIP and CCCP) were effective in enhancing permeability of antibiotics within the osteoblasts and facilitated killing of intracellular S. aureus. Confocal laser scanning microscopy (CLSM) showed increased uptake of propidium iodide within osteoblasts in presence of PIP and CCCP. BMP-2 had no effect on growth of S. aureus either alone or in combination with antibiotics. Combined application of antibiotics and natural agents could help in the treatment of osteoblast infected intracellular bacteria and biofilms associated with osteomyelitis.
© 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1086-1092, 2018. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  Staphylococcus aureus; biofilm; intracellular bacteria; orthopaedic infection; osteoblast

Mesh:

Substances:

Year:  2017        PMID: 28885721     DOI: 10.1002/jor.23723

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  7 in total

1.  Recalcitrant methicillin-resistant Staphylococcus aureus infection of bone cells: Intracellular penetration and control strategies.

Authors:  Kristin Yu; Lee Song; Hyunwoo Paco Kang; Hyuk-Kwon Kwon; Jungho Back; Francis Y Lee
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

Review 2.  In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.

Authors:  Florian C Marro; Lélia Abad; Ariel J Blocker; Frédéric Laurent; Jérôme Josse; Florent Valour
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.790

3.  Real time monitoring of Staphylococcus aureus biofilm sensitivity towards antibiotics with isothermal microcalorimetry.

Authors:  Andi Rofian Sultan; Mehri Tavakol; Nicole A Lemmens-den Toom; Peter D Croughs; Nelianne J Verkaik; Annelies Verbon; Willem J B van Wamel
Journal:  PLoS One       Date:  2022-02-16       Impact factor: 3.240

Review 4.  Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis.

Authors:  Anja R Zelmer; Renjy Nelson; Katharina Richter; Gerald J Atkins
Journal:  Bone Res       Date:  2022-08-12       Impact factor: 13.362

5.  Bone morphogenetic proteins - 7 and - 2 in the treatment of delayed osseous union secondary to bacterial osteitis in a rat model.

Authors:  Lars Helbig; Georg W Omlor; Adriana Ivanova; Thorsten Guehring; Robert Sonntag; J Philippe Kretzer; Susann Minkwitz; Britt Wildemann; Gerhard Schmidmaier
Journal:  BMC Musculoskelet Disord       Date:  2018-07-27       Impact factor: 2.362

6.  Trace amines produced by skin bacteria accelerate wound healing in mice.

Authors:  Arif Luqman; Muhammad Zainul Muttaqin; Sumah Yulaipi; Patrick Ebner; Miki Matsuo; Susanne Zabel; Paula Maria Tribelli; Kay Nieselt; Dewi Hidayati; Friedrich Götz
Journal:  Commun Biol       Date:  2020-06-01

7.  Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease.

Authors:  Karthik Subramanian; Federico Iovino; Vasiliki Tsikourkitoudi; Padryk Merkl; Sultan Ahmed; Samuel B Berry; Marie-Stephanie Aschtgen; Mattias Svensson; Peter Bergman; Georgios A Sotiriou; Birgitta Henriques-Normark
Journal:  EMBO Mol Med       Date:  2020-09-28       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.